Efficacy of Saccharomyces boulardii for treatment of horses with acute enterocolitis

OBJECTIVE: To evaluate the viability of Saccharomyces boulardii after PO administration in clinically normal horses and its efficacy as a treatment for horses with acute enterocolitis. DESIGN: Prospective study. ANIMALS: 5 clinically normal horses and 14 horses with acute enterocolitis. PROCEDURE: Feces were collected from 5 clinically normal horses and submitted for microbial culture for 2 days prior to administration of a lyophilized form of S. boulardii (25 or 50 g, PO, q 12 h) for 10 days. Feces were collected for microbial culture 5 and 10 days after treament initiation and 10 days after treatment was discontinued. Fourteen horses with acute enterocolitis were randomly allocated to receive a placebo or S. boulardii (25 g), PO, every 12 hours for 14 days. RESULTS: S. boulardii was not detected in feces of clinically normal horses. After administration, yeast survived within the gastroinestinal tract but did not permanently colonize it. In horses with acute enterocolitis, the severity and duration of gastrointestinal tract disease during hospitalization were significantly decreased in horses receiving S. boulardii, compared with horses receiving the placebo. CONCLUSIONS AND CLINICAL RELEVANCE: Administration of S. boulardii may help decrease the severity and duration of clinical signs in horses with acute enterocolitis.     

布拉酵母菌对黄曲霉毒素B1脱毒特性研究

本试验研究了不同菌体预处理、不同浓度菌体、不同作用时间、不同pH环境对布拉酵母菌脱除黄曲霉毒素B₁(AFB₁)效果的影响。结果发现,布拉酵母菌脱除AFB₁的主要机理是吸附作用;与2 mol/L HCl 121 ℃处理30 min相比,100 ℃处理30 min更有利于布拉酵母菌对AFB₁的脱毒;强酸性和偏碱性的环境也利于布拉酵母菌对AFB₁的脱毒。     

布拉迪酵母菌的生物学功能、作用机制及其应用

布拉迪酵母是酿酒酵母的亚种,具有耐高温和耐胆盐的特性,通过改变病原菌的表面减少肠道致病菌。其分泌物能提高动物体内的酶活,从而促进营养物质的消化吸收;还能通过干扰促炎因子来提高机体抗炎作用。布拉迪酵母临床上可用于防治抗生素相关性腹泻、艰难梭菌感染、旅行者腹泻、肠易激综合征、克罗恩病等疾病。此外,布拉迪酵母作为一种饲料添加剂通过了欧洲、北美等认证。在畜禽应用中,布拉迪酵母可降低畜禽料重比、改善生产性能、降低腹泻,同时可以通过促进肠道有益菌的增殖,产生乳酸降低肠道致病菌的含量、调节肠道菌群平衡,促进机体免疫因子的释放和免疫器官的发育,进而增强机体免疫力。作者针对布拉迪酵母生物学功能及其作用机制、在畜禽养殖及人临床上的应用进行综述,以期为其进一步的研究和广泛应用提供参考。     

Bacillus cereus var. toyoii and Saccharomyces boulardii increased feed efficiency in broilers infected with Salmonella enteritidis

1. The effect on feed efficiency of two probiotics, one prepared with Saccharomyces boulardii and the other with Bacillus cereus var. toyoii, was tested in broilers infected with Salmonella enteritidis. 2. One-day-old chicks were divided at random into three groups and fed commercial feed devoid of antibiotics: group 1 was fed with non-supplemented feed, group 2 was supplemented with S. boulardii and group 3 with B. cereus. At 14 d of age the animals were challenged by the oral route with 1 x 10(7) viable S. enteritidis. 3. At d 47, average live weights were: group 1, 1.77 kg, group 2, 1.89 kg and group 3, 2.06 kg, and were significantly different. Feed conversion rates were 2.61 for group 1, 2.35 for group 2 and 2.30 for group 3. 4. We conclude that both probiotics improved feed efficiency in broilers.     

Anthelmintic effect of levamisole hydrochloride or ivermectin on tissue toxocariasis of mice

Paranatal transmission of Toxocara canis infection could be prevented in pups if an effective drug were administered to pregnant bitches. This drug also could eliminate the larvae in dogs that have been experimentally infected repeatedly to produce protective immunity. For these reasons, we assayed the effect of 2 doses of levamisole hydrochloride or ivermectin on T canis larvae. Mice (5 groups) were infected with 1,000 infective T canis larvae and then treated with 2 different dosages of levamisole hydrochloride (6 mg/kg or 12 mg/kg, given subcutaneously), 2 different dosages of ivermectin (0.2 mg/kg or 0.4 mg/kg, given IM) or 0.15M NaCl (given subcutaneously) once a day from days 15 to 28 of infection. On day 33 of infection, the parasites in liver, lungs, brain, and carcass were obtained and compared between groups. The smaller dosage of levamisole hydrochloride (6 mg/kg) significantly decreased only carcass parasitism to 17% of that in the controls, but did not affect significantly the total parasite load. The larger dosage of levamisole hydrochloride (12 mg/kg) decreased the infection in all organs, but particularly in carcass and brain; total parasitism was only 36% of that in the controls. The smaller dosage of ivermectin (0.2 mg/kg) significantly increased the number of larvae in the lungs to 550% of that in the controls, but it did not significantly affect the total parasite load. The larger dosage of ivermectin (0.4 mg/kg) significantly decreased only brain parasitism, but liver and total parasitism were decreased to 40% and 57%, respectively, compared with that in the controls.(ABSTRACT TRUNCATED AT 250 WORDS)     

New infection with Corynebacterium pseudotuberculosis reduces wool production

SUMMARY The effect of natural Corynebacterium pseudotuberculosis infection on wool production and quality in sheep was examined in light of evidence that artificial C pseudotuberculosis infection causes wool production loss. A toxin ELISA was used to identify sheep that had been infected with C pseudo tuberculosis. Greasy and clean fleece weights and fibre diameter were compared in infected and uninfected sheep. C pseudotuberculosis infection caused a 3.8 to 4.8% decrease in greasy wool production and a 4.1 to 6.6% decrease in clean wool production. C pseudotuberculosis infection did not affect fibre diameter. The effects of caseous lymphadenitis (the disease caused by C pseudotuberculosis infection) cause an annual loss of about $17 million in wool production to the Australian wool industry.     

Human toxocariasis and direct contact with dogs

Toxocariasis in man is traditionally thought to be contracted through the ingestion of eggs from contaminated soil. The disease may manifest itself in different syndromes such as ocular larval migrans, visceral larval migrans and covert toxocariasis. This paper assesses the evidence for the soil contamination hypothesis and proposes that direct contact with dogs may provide a better explanation of the epidemiology of the disease. Hair was collected from 60 dogs from various places in Ireland and the UK and examined for the presence of Toxocara canis eggs. T. canis eggs were found in the hair of 25 per cent of the dogs; in total, 71 eggs were recovered, of which 4.2 per cent were embryonated and 23.9 per cent were embryonating. The maximum densities of the embryonating and embryonated eggs were 180 and 20 eggs per gram of hair, respectively, much higher than the densities reported for soil samples. It is suggested that dogs infected with T. canis may infect people by direct contact.     

Oral administration of Saccharomyces boulardii alters duodenal morphology,enzymatic activity and cytokine production response in broiler chickens

The present study evaluated the effects of Saccharomyces boulardii on duodenal digestive enzymes, morphology and cytokine induction response in broiler chicken. A total of 200 birds were allotted into two groups (n = 100) and each group divided into five replications (n = 20). The control group was fed basal diet in addition to antibiotic (virginiamycin 20 mg/kg), and treatment group received (1 × 10⁸ colony‐forming units/kg feed) S. boulardii in addition to basal diet lasting for 72 days. The results compared to control group revealed that adenosine triphosphatase, gamma glutamyl transpeptidase, lipase and trypsin activities were higher, while, no significant improvement was observed in amylase activities in the duodenum of the treatment group. Moreover, morphological findings showed that villus height, width and number of goblet cells markedly increased. Additionally, transmission electron microscopy visualized that villus height, width and structural condensation significantly increased in the treatment group. The immunohistological observations showed increased numbers of immunoglobulin A (IgA)‐positive cells in the duodenum of the treatment group. Meanwhile, cytokine production levels of tumor necrosis factor‐α, interleukin (IL)‐10, transforming growth factor‐β and secretory IgA markedly increased, and IL‐6 statistically remained unchanged as compared to the control group. These findings illustrated that initial contact of S. boulardii to the duodenum has significant impact in improving enzymatic activity, intestinal morphology and cytokine response in broiler chicken.     

Laboratory diagnosis of human toxocariasis

Toxocariasis is a helminth zoonosis caused by infection with the larvae of Toxocara spp. ascarid worms. Only two species, Toxocara canis and Toxocara cati, are recognised as causative agents of human disease. The best choice for serodiagnosis of the generalised forms of toxocariasis, visceral larva migrans (VLM) or covert toxocariasis, relies upon the initial use of TES-ELISA, after which any positive result should subsequently be tested by Western blotting (WB). Covert toxocariasis is mostly a benign infection, so a large majority of infected subjects are asymptomatic or have very few symptoms and therefore go undiagnosed. In this form, this helminthosis is often self-limiting, leaving residual specific antibodies. A positive serodiagnosis caused by residual antibodies that do not have any diagnostic significance can be associated with any infectious or non-infectious disease. If separated from the ongoing clinical and laboratory context, such a positive result has no diagnostic value and should be only taken into account after the possible etiologies of any observed syndromes have been ruled out. Unlike the methods used for the immunodiagnosis of bacterial, viral or protozoal (toxoplasmosis) infections, it is not possible with toxocariasis to assess the age of the presence of specific IgG using the levels of specific IgM because IgM antibodies can be found throughout the course of helminthiasis. The detection of other classes of immunoglobulins, namely IgE and IgA, the subclasses, namely IgG4 or circulating Ag was proven to be unable to discriminate between active and self-cured generalised toxocaral infections. Currently, the diagnosis of an active covert toxocariasis relies upon indirect arguments, e.g., the presence of otherwise unexplained symptoms along with blood eosinophilia and/or elevated levels of eosinophil cationic protein (ECP). This situation is far from ideal and more research should be carried out to solve this difficult problem.     

Transplacental infection in mice inoculated with Getah virus

Transplacental transmission was demonstrated in pregnant mice subcutaneously inoculated with Getah virus. Viremia was shown in the infected dams, and high-titered virus was detected in the placenta and later in the fetus, suggesting virus invasion of the fetus through hematogenous infection of the placenta. High-titered virus was shown in the fetal brain and muscle and in the brain of the young dying soon after birth. Intrauterine infection resulted in a reduction of the litter size, number of young born alive and survival rate to 1 week of age. These results were further corroborated by necropsy performed several days after virus inoculation. The stage of gestation at the time of virus inoculation greatly influenced these results. Dams inoculated at 12 days of gestation delivered all dead babies, whereas virus inoculation at 5 days of gestation had no effect on the number of young born alive. The dams inoculated at 8 days of gestation had reduced litter sizes and those inoculated at 16 days of gestation produced slightly fewer live babies. Gestational stage at the time of virus inoculation also influenced viral growth in fetuses and placentas. The infection rate was low in dams inoculated at 5 days of gestation, high in dams inoculated at 8 or 16 days of gestation and 100% in dams inoculated at 12 days of gestation. High-titered virus was shown in placentas and fetuses of the dams inoculated at 8, 12 or 16 days of gestation. These results suggest that Getah virus may readily cross the placental barrier through hematogenous infection of the placenta in mice.     

Natural infection of nude mice with low-virulent mouse coronavirus

The outbreak of wasting disease of nude mice occurred in the laboratory colony of a Pharmaceutical Company. The viruses producing cytopathic effect with syncytium formation were isolated from the wasted nude mice by DBT cells, and were identified as mouse coronavirus by direct immunofluorescence. The nude mouse colony was closed and all the nude mice (about 500) were killed by the reason of disease control. At autopsy about 60% of nude mice showed necrotic hepatitis. By the virus isolation to see the source of contamination, viruses were isolated from the feces of apparently healthy mice of ICR, CDF1, DBA/2 and C3H, and from human cancer cell line stocked in liquid nitrogen. In experimental infection, the isolates produced only mild hepatitis in ICR mice treated with cortisone. By cross-neutralization test, the nude isolate reacted closely with the virus from C3H mice but not with the virus from cancer cell line. The isolates from nude and C3H mice produced experimentally wasting disease with necrotic hepatitis in nude mice. These findings suggest that wasting disease in nude mice might be caused by low-virulent mouse coronavirus shed in feces from C3H mice introduced before the outbreak of disease.     

Effects of Saccharomyces cerevisiae subspecies boulardii CNCM I-1079 on feed intake by healthy beef cattle treated with florfenicol and on health and performance of newly received beef heifers

The effects of a live yeast supplement [Saccharomyces cerevisiae subspecies boulardii CNCM I-1079; ProTernative Stress Formula (PTSF) yeast, Ivy Natural Solutions, Overland Park, KS] on DMI, performance, and health of beef cattle were evaluated in 3 experiments. In Exp. 1, a pilot study was conducted with 10 healthy beef steers fed a 65% concentrate diet to evaluate the effects of florfenicol (s.c. in the neck vs. sterile water injection) on DMI. Steers injected with florfenicol had 15.6 (P = 0.092) and 22.2% (P = 0.015) decreases in DMI compared with controls on the day of and day after injection, respectively, with no differences for the remainder of the 7-d period. In the main study of Exp. 1, healthy beef steers (6 pens of 5 steers each/treatment) were fed the control or PTSF yeast diets (0.5 g of yeast x steer(-1) x d(-1)) for 5 d before being injected s.c. with florfenicol. Compared with the 5 d before injection, DMI decreased after injection, but it did not differ (P > 0.66) between treatments on the day of and day after injection. By the second day after injection, DMI tended (P = 0.107) to increase for steers fed PTSF yeast vs. control steers, with a trend for a similar pattern on the third day after injection (P = 0.197). No differences were noted between treatments for the remainder of the 7-d period or for the subsequent 2 wk. In Exp. 2, 3 loads of beef heifers (277 heifers; average initial BW = 230.3 kg) were shipped from auction barns and assigned randomly to 1 of 2 treatments (5 pens/treatment in each load) during 35-d receiving periods: 1) control = 65% concentrate receiving diet; or 2) PTSF yeast = 65% concentrate receiving diet with PTSF yeast added to supply 0.5 g of yeast x heifer(-1) x d(-1). All heifers were treated with florfenicol on arrival, and PTSF yeast heifers received approximately 1 g of yeast via an oral paste at the time of processing. Averaged over the 3 loads, treatments did not affect (P > or = 0.12) DMI, ADG, or G:F during the 35-d period, but the percentage of cattle treated once or more for bovine respiratory disease (BRD) was greater for control (P = 0.04) than for PTSF yeast heifers (24.0 vs. 13.78% respectively). In Exp. 3, 2 loads of beef heifers (180 heifers; average initial BW = 209.0 kg) that were not treated with antibiotic at the time of arrival processing were fed a 70% concentrate receiving diet and assigned the same 2 treatments as in Exp. 2. No differences (P > 0.72) were noted between treatments in ADG, DMI, and G:F for the 35-d receiving period, and BRD morbidity pooled across loads did not differ between treatments (40.2 vs. 33.1% for control vs. PTSF yeast). Providing PTSF yeast in an oral paste at the time of processing combined with the addition of 0.5 g of yeast x animal(-1) x d(-1) in the diet had little effect on receiving period performance; however, it decreased BRD morbidity in heifers given florfenicol on arrival but was without effect on BRD morbidity in heifers that did not receive a prophylactic antibiotic.     

弓形虫慢性感染小鼠脑组织差异表达蛋白质组学

通过比较弓形虫慢性感染小鼠与健康小鼠的脑组织,筛选差异表达的鼠脑蛋白质,以期从蛋白质组学角度挖掘其导致中枢神经系统(central nervous system,CNS)损伤的机制,并为寻找生物标志物提供靶标。建立弓形虫PRU株慢性感染小鼠模型,运用iTRAQ技术,结合LC-MS/MS分析差异表达蛋白质,并采用荧光定量PCR和Western blot验证iTRAQ数据。结果共鉴定出4 983个蛋白,差异表达蛋白461个,其中215个蛋白上调表达,246个蛋白下调表达,差异蛋白主要涉及代谢和神经过程等通路。结果表明,iTRAQ结合LCMS/MS技术能快速有效地进行蛋白质组学研究,为研究弓形虫慢性感染致宿主CNS损伤机制以及发现新的生物标志物提供参考。     

The effect of experimental infection with Rhodococcus equi on immunodeficient mice

To investigate the pathogenesis of respiratory lesions caused by the facultative intracellular pathogen, Rhodococcus equi, pulmonary clearance was compared in four groups of genetically defined mice, chosen for their specific deficits in immune and inflammatory responses. Complement-deficient A/J, immunodeficient nu/nu (nude), scid/scid.bg/bg (SCID/beige), C57BI/6J.bg/bg (beige) and normal Swiss mice (SW) received approximately 10(7) R. equi intranasally on day 0. Bacterial clearance was assessed in lung, liver and spleen on days 1, 4, 7 and 14. Pulmonary clearance was not significantly different between SW and A/J mice. Beige mice cleared R. equi more rapidly and completely than A/J and SW, indicating that deficits in phagocytic and NK cell function associated with the bg/bg gene did not compromise clearance. Pulmonary clearance in immunodeficient SCID/beige mice paralleled that of the SW and A/J mice initially but bacterial proliferation produced significant differences from SW mice at day 14. Nude mice were unable to clear R. equi from day 1, resulting in the death of two nude mice at day 11. Both SCID/beige and nude mice developed severe pyogranulomatous bronchopneumonia, whereas A/J and SW mice developed transient pulmonary lesions. Beige mice developed minimal lung lesions. Significant systemic bacterial proliferation occurred only in nude and SCID/beige mice. We conclude that deficiencies in complement components, phagocytic and NK cells do not impair the pulmonary clearance of R. equi but that a competent cellular immune system is required to prevent pneumonia and death. The difference in early phase pulmonary clearance in nude and SCID/beige mice indicates two phases are important for clearance. An acapsular mutant of R. equi was completely cleared from the lungs of SCID/beige mice suggesting an important role for the capsule in virulence for mice.     

猪圆环病毒2型感染裸鼠及BALB/c小鼠的研究

用猪圆环病毒2型（PCV2）经腹腔注射BALB/c小鼠及裸鼠各15只,每隔2周1次,共感染3次.BALB/c小鼠初次、再次感染后均未出现明显的临床症状,仅有2只小鼠出现病理变化;从血清中可检测到PCV2核酸及其ORF2抗体;同时淋巴细胞增殖反应显著增强,NK和CTL细胞杀伤率显著升高;CD4^＋、CD8^＋、CD3^＋T淋巴细胞及CD19^＋B淋巴细胞数量显著减少.裸鼠也未出现明显的临床症状,从血清中可检测到PCV2核酸,但未检测到PCV2 ORF2抗体;除NK细胞杀伤率显著升高外,其余免疫学指标无显著改变.结果表明,BALB/c小鼠比裸鼠对PCV2易感,各项免疫学指标变化与PCV2感染猪一致,但不表现临床症状,仅个别BALB/c小鼠出现病理变化,说明BALB/c小鼠对PCV2不如猪易感.